VEGFA and pulmonary arterial hypertension: We utilized cell models that we think have strong relevance to human disease, particularly with reduction in BMPR2 levels as seen in numerous PAH patient subgroups as well as stimulation of the cells with a growth factor, VEGF, that is known to be elevated in patients with some forms of PAH [15,25,26,27].